Hypertension
3 COMMENTS - Jun 15, 2013 12:40 EDT
The new guidelines make <140 mm Hg the treatment target for all individuals, with a few minor exceptions, and say that all the drug classes have a role in reducing blood pressure. In addition, the ESH/ESC guidelines emphasize a role for ABPM and reiterate their emphasis on combination therapy.
Arrhythmia/EP
Jun 18, 2013 09:30 EDT
So concluded a new laboratory study, with acknowledged limitations, that simulated the in vivo stresses imposed on implanted leads.
Hypertension
4 COMMENTS - Jun 17, 2013 11:00 EDT
At the ESH meeting, two experts took opposing views concerning the current war on salt. One believes the current salt/sodium targets were simply pulled out of a hat and have no scientific basis at all, while the other believes the targets are necessary to help start a low-sodium environment for future generations, lowering their potential risks of hypertension and cardiovascular disease.
Hypertension
3 COMMENTS - Jun 17, 2013 09:45 EDT
Daytime blood pressure measured by 24-hour ambulatory blood-pressure monitoring was reduced by 8.9/3.7 mm Hg, report investigators. The data suggest that the addition of spironolactone might be beneficial in this hard-to-treat patient population already receiving multiple antihypertensive medications, they add.

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Editorial series
Jun 3, 2013 09:45 EDT
Learn how Dr Richard Schatz went from the University of Buffalo to medical school at Duke to being one of the pioneers of the stent, all by following his mother's directive.
Editorial series
Jun 5, 2013 15:05 EDT
View our slideshow for a top-line summary of news-making presentations, including ADVANC/E<, the alarming rise of STEMI in young women, SCAAR, and SOURCE XT.
Editorial series
1 COMMENT - May 23, 2013 10:58 EDT
View our slideshow for a top-line summary of news-making presentations including NCDR PINNACLE, BRUISE CONTROL, and the long-term PROTECT-AF analysis.
Editorial series
May 2, 2013 08:45 EDT
Join Drs Melissa Walton-Shirley and Timothy Gardner for a calm, in-depth discussion on some of the issues raised by President Obama's healthcare reform, including 30-day readmission rates and penalties.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Topolog by Dr Eric Topol
Topolog
May 08, 2013 17:00 EDT
The GISSI group's impressive, collaborative study just published in NEJM puts to bed any lingering theory stipulating a positive effect of fish oils to prevent heart disease in patients who have not had an MI and do not have HF.
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Most popular
Membership is free!
Inside Themes
Acute Coronary Syndromes
Interventional/Surgery
Interventional/Surgery
Arrhythmia/EP
Lipid/Metabolic
Acute Coronary Syndromes
Acute Coronary Syndromes
Acute Coronary Syndromes
Lipid/Metabolic
Lipid/Metabolic
Interventional/Surgery
Hypertension
Interventional/Surgery
Hypertension
Clinical cardiology
Clinical Cardiology
Academic collaboration
Mayo Clinic joins forces with theheart.org to provide unique perspective on clinical trials, patient care, news, and events in cardiology

Press center
Latest cardiology-related press releases and communications from industry
Also on theheart.org
The Cardiology Show
1 COMMENT - Mar 12, 2013 16:11 EDT
Join our international panel for a review of the top research from the American College of Cardiology 2013 Scientific Sessions.
Editorial series
1 COMMENT - Feb 25, 2013 15:10 EST
Join heartwire's Shelley Wood for an indepth discussion with Dr Rita Redberg on the need for better premarket studies for cardiovascular devices and how to balance innovation with safety.